NeoPhore Company
NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
Funding Status:
N/A
Industry:
Preventive Medicine
Number Of Exists:
N/A
Technology:
Drug Discovery
Founded Date:
2017
Investor Type:
N/A
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Employee Number:
Undisclosed
Investment Stage:
N/A